News for Bull Horn Holdings Corp. (BHSE)

/PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) (the "Company"), a biopharmaceutical company developing innovative cell therapy platforms...

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.39%

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.59%

SPAC Bull Horn Holdings (BHSE) stockholders have approved a planned merger with Coeptis Therapeutics (COEP) that will result in the cell therapy developer uplisting its shares to Nasdaq.

/PRNewswire/ -- Coeptis Therapeutics, Inc. (OTC PINK: COEP) ("Coeptis" or "the Company"), a biopharmaceutical company developing innovative cell therapy...

Coeptis Therapeutics (COEP) plans to merge with SPAC Bull Horn Holdings (BHSE) and uplist its shares to Nasdaq

Coeptis Therapeutics, a biopharma compan  developing cell therapy platforms for cancer, agreed to go public through a deal with SPAC Bull Horn Holdings (BHSE)

Bull Horn Holdings Corp. (NASDAQ:BHSE) was the target of a significant growth in short interest in the month of November. As of November 15th, there was short interest totalling 5,400 shares, a growth of 25.6% from the October 31st total of 4,300 shares. Currently, 0.1% of the company’s shares are sold short. Based on an […]

Bull Horn Holdings Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q MIAMI BEACH, FLORIDA, SEPTEMBER 3, 2021 - Bull... | September 3, 2021